| ATHA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATHA shares outstanding history going back to 9/18/2020:
Also see: ATHA Market Cap History ATHA YTD Return |
As of 11/5/2025 Athira Pharma has 3.94 million ATHA shares outstanding. Investors often track the ATHA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ATHA share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 9/18/2020.

| ATHA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATHA shares outstanding history going back to 9/18/2020:
Also see: ATHA Market Cap History ATHA YTD Return |
| ATHA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
ATHA Historical Shares Outstanding: +6.30% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| ATHA Stock Price Chart |
| About LeonaBio Inc |
| Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, small molecule positive modulator of the hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) system for CNS disorders. We show 22 historical shares outstanding datapoints in our coverage of ATHA's shares outstanding history. Understanding the changing numbers of ATHA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ATHA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ATHA by allowing them to research ATHA shares outstanding history as well as any other stock in our coverage universe. |
| ATHA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ATHA Share Performance |
| Shares Outstanding Peers |
| Athira Pharma (ATHA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ATHX Shares Outstanding History ATIP Shares Outstanding History ATIS Shares Outstanding History ATLN Shares Outstanding History ATNF Shares Outstanding History ATNX Shares Outstanding History ATOS Shares Outstanding History ATRA Shares Outstanding History ATRC Shares Outstanding History ATRI Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.